The largest blog for reading the latest medical research on all disease, the prevention and its treatment . Pulled from variety of sources

Tuesday, March 6, 2018

Japan NGO launches forum to lift awareness of male breast Cancer disease

Cancer disease Net Japan, a Tokyo-based nonprofit Administration, soon organized an event to bring together male patients being treated for breast Cancer disease & generate greater public understanding of the illness. In 2015, further than 87,000 people were newly diagnosed by breast Cancer disease in Japan. by no curing strategies specifically targeted at male patients, curing procedures are similar to those for ladies. The 3 male entrants who took portion in the premier such event, dubbed "Men's BC (breast Cancer disease)," said tiny data is obtainable on male breast Cancer disease — even on the net. "In terms of male breast Cancer disease, there is clearly no society of patients," said Shimomura, who was a guest speaker at the gathering.


23andMe could This time purvey breast Cancer disease geneticaltest by no prescription needed

23andMe could This time purvey breast Cancer disease geneticaltest by no prescription neededPhoto: Michael Macor, The Chronicle Anne Wojcicki, co-founder & chief executive officerof 23andMe on phase during... The FDA on Tuesday authorized Mountain View's 23andMe to purvey a Analysis for a breast Cancer disease geneticalmutation directly to consumers — the premier time the agency has allowed the discount of a geneticaltest for Cancer disease danger without a doctor's prescription. The Analysis analyzes a saliva sample to set whether a lady has an increased danger for emerging breast Cancer disease by detecting geneticalvariants found on the BRCA1 & BRCA2 genes. Many of 23andMe's tests for geneticalmutations related to other illnesses, like celiac illness & a blood clotting Complication, have been obtainable to consumers without a prescription for a year. The Analysis authorized by the FDA covers only 3 of about one,000 variants found on the BRCA1 & BRCA two genes.

23andMe can now sell breast cancer genetic test with no prescription needed

23andMe could This time say you about your breast Cancer disease danger

as declared in A 23andMe kit Lydia Ramsey/Business InsiderThe Food and Drug Administration only allowed 23andMe to provide tests which testyour geneticaldanger for Cancer disease. 23andMe could once once more say you about your geneticaldanger for Cancer disease. which makes 23andme the premier direct-to-user test allowed to provide some data about your geneticaldanger for Cancer disease. Their presence indicates an increased danger of breast Cancer disease, however which doesn't mean a man going to necessarily get the illness — only which the chances are higher. generality American ladies have a seven% chance of emerging breast Cancer disease with 70, according to the Centers for Disease Control and Prevention.

Food and Drug Administration confirms premier direct-to-user Analysis for breast Cancer disease danger

Federal regulators confirmed the premier direct-to-user Analysis for the BRCA genes, that promote the danger of breast & ovarian Cancer disease, the agency reported on Tuesday. The 3 specific BRCA1/BRCA2 breast Cancer disease gene mutations are generality popular in people by Ashkenazi (Eastern European) Jewish ancestry, accounting for further than 90 % of their danger of heritable breast & ovarian Cancer disease. "A negative result doesn't rule out the potential that an individual totes other BRCA mutations that promote Cancer disease danger," the Food and Drug Administration warned. Those were the premier Food and Drug Administration-confirmed direct-to-user tests for geneticaldanger of any illness or condition, that the agency said can help people make lifestyle decisions. The BRCA Analysis going to be portion of 23andme's $199 Health + Ancestry Analysis.

FDA approves first direct-to-consumer test for breast cancer risk


collected by :Lucy William

No comments:

Post a Comment